Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Magnan

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Journal of Occupational Health|December 6, 2008
Occupational allergic contact dermatitis and asthma due to a single low molecular weight agentPhilippe Moulin, Antoine Magnan, Marie-Pascale Lehucher-Michel
Presse Medicale (Paris, France : 1983)|November 4, 2018
[Publication output of French university hospitals during 2006-2015: Trends and position in the national health research landscape]Lesya Baudoin, Vincent Akiki, Antoine Magnan, et al.
Frontiers in Immunology|October 26, 2018
CD9 Tetraspanin: A New Pathway for the Regulation of Inflammation?Carole Brosseau, Luc Colas, Antoine Magnan, et al.
Clinical Drug Investigation|May 19, 2012
Safety and tolerability of an SQ-standardized GRAss ALlergy immunotherapy tablet (GRAZAX®) in a real-life setting for three consecutive seasons - the GRAAL trialFrançois Wessel, Antoine Chartier, Jean-Pierre Meunier, et al.
Frontiers in Immunology|August 6, 2019
Early Identification of Chronic Lung Allograft Dysfunction: The Need of BiomarkersAdrien Tissot, Richard Danger, Johanna Claustre, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 7, 2021
Type 2 immunity-driven diseases: Towards a multidisciplinary approachDorian Hassoun, Olivier Malard, Sébastien Barbarot, et al.
Respiratory Research|March 2, 2011
Differences in allergen-induced T cell activation between allergic asthma and rhinitis: Role of CD28, ICOS and CTLA-4Karine Botturi, Yannick Lacoeuille, Arnaud Cavaillès, et al.
Respiratory Medicine|February 14, 2009
Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacyAnaïs Pipet, Karine Botturi, Domitille Pinot, et al.
Presse Medicale (Paris, France : 1983)|November 29, 2007
[Allergy and refractory asthma: new etiological and treatment pathways]Alice Cleenewerck, Chantal Raherison, Antoine Magnan, et al.
American Journal of Respiratory and Critical Care Medicine|August 28, 2014
IL-17 in severe asthma. Where do we stand?Julie Chesné, Faouzi Braza, Guillaume Mahay, et al.
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Journal of Occupational Health|December 6, 2008
Occupational allergic contact dermatitis and asthma due to a single low molecular weight agentPhilippe Moulin, Antoine Magnan, Marie-Pascale Lehucher-Michel
Presse Medicale (Paris, France : 1983)|November 4, 2018
[Publication output of French university hospitals during 2006-2015: Trends and position in the national health research landscape]Lesya Baudoin, Vincent Akiki, Antoine Magnan, et al.
Frontiers in Immunology|October 26, 2018
CD9 Tetraspanin: A New Pathway for the Regulation of Inflammation?Carole Brosseau, Luc Colas, Antoine Magnan, et al.
Clinical Drug Investigation|May 19, 2012
Safety and tolerability of an SQ-standardized GRAss ALlergy immunotherapy tablet (GRAZAX®) in a real-life setting for three consecutive seasons - the GRAAL trialFrançois Wessel, Antoine Chartier, Jean-Pierre Meunier, et al.
Frontiers in Immunology|August 6, 2019
Early Identification of Chronic Lung Allograft Dysfunction: The Need of BiomarkersAdrien Tissot, Richard Danger, Johanna Claustre, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 7, 2021
Type 2 immunity-driven diseases: Towards a multidisciplinary approachDorian Hassoun, Olivier Malard, Sébastien Barbarot, et al.
Respiratory Research|March 2, 2011
Differences in allergen-induced T cell activation between allergic asthma and rhinitis: Role of CD28, ICOS and CTLA-4Karine Botturi, Yannick Lacoeuille, Arnaud Cavaillès, et al.
Respiratory Medicine|February 14, 2009
Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacyAnaïs Pipet, Karine Botturi, Domitille Pinot, et al.
Presse Medicale (Paris, France : 1983)|November 29, 2007
[Allergy and refractory asthma: new etiological and treatment pathways]Alice Cleenewerck, Chantal Raherison, Antoine Magnan, et al.
American Journal of Respiratory and Critical Care Medicine|August 28, 2014
IL-17 in severe asthma. Where do we stand?Julie Chesné, Faouzi Braza, Guillaume Mahay, et al.
Pageof 11